14-3-3 σ possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid

Cancer Letters

Volumn 196, Issue 1, 2003, Pages 87-91

  Ito, Yasuhiro ^a   Miyoshi, Eiji ^a   Uda, Erika ^a   Yoshida, Hiroshi ^a   Uruno, Takashi ^a   Takamura, Yuuki ^a   Miya, Akihiro ^a   Kobayashi, Kaoru ^a   Matsuzuka, Fumio ^a   Matsuura, Nariaki ^b   Kakudo, Kennichi ^c   Kuma, Kanji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

14 3 3 ; Immunohistochemistry; Thyroid carcinoma

Indexed keywords

BINDING PROTEIN; JUN ACTIVATION DOMAIN BINDING PROTEIN; PROTEIN P27; UNCLASSIFIED DRUG;

ARTICLE; CANCER SIZE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0037969082     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00129-0     Document Type: Article

References (22)

1. Aldinger K.A., Samaan N.A., Ibanez M., Hill C.S. Jr. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant-cell carcinoma of the thyroid. Cancer. 41:1978;2267-2275.
2. Ito Y., Yoshida H., Nakano K., Takamura Y., Kobayashi K., Yokozawa T., Matsuzuka F., Matsuura N., Kuma K., Miyauchi A. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation. Pathol. Res. Pract. 198:2002;397-402.
3. Goto A., Sakamoto A., Machinami R. An immunohistochemical analysis of cyclin D1, p53 and p21 waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland. Pathol. Res. Pract. 197:2001;217-222.
4. Ito Y., Kobayashi T., Takeda T., Komoike Y., Wakasugi E., Tamaki Y., Tsujimoto M., Matsuura N., Monden M. Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues. Br. J. Cancer. 74:1996;1269-1274.
5. Khoo M.L.C., Beasley N.J.P., Ezzat S., Freeman J.L., Asa S.L. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 87:2002;1814-1818.
6. kip1 and Ki-67 in benign and malignant thyroid tumors. Mod. Pathol. 11:1998;169-174.
7. Resnick M.B., Schacter P., Finkelsteini Y., Kellner Y., Cohen O. Immunohistochemical analysis of p27/Kip1 expression in thyroid carcinoma. Mod. Pathol. 11:1998;735-739.
8. Ito Y., Yoshida H., Nakano K., Kobayashi K., Yokozawa T., Hirai K., Matsuzuka F., Matsuura N., Kuma K., Miyauchi A. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissue. Int. J. Mol. Med. 9:2002;373-376.
9. Claret F.X., Hibi M., Dhut S., Toda T., Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature. 383:1996;453-457.
10. Tomoda K., Kubota Y., Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27/kip1 is instigated by Jab1. Nature. (398):1999;160-165.
11. Hedinger C., Williams E.D., Sobin L.H. Histological Typing of Thyroid Tumours. World Health Organization. 2nd ed. 1988;Springer-Verlag, New York.
12. Fagin J.A. Braverman L.E., Utiger R.D. The Thyroid. 8th ed. 2000;886-898 Lippencott Williams & Wilkins.
13. Takebe K., Date M., Yamamoto Y., Ogino T., Takeuchi Y. Mass screening for thyroid cancer with ultrasonography (in Japanese). KARKINOS. 7:1994;309-317.
14. Koike A., Naruse T. Incidence of thyroid cancer in Japan. Semin. Surg. Oncol. 7:1991;107-111.
15. Franceschi S., Boyle P., Maissonneuve P., La Vecchia C., Burt A.D., Kerr D.J., Farlane G.J. The epidemiology of thyroid carcinoma. Crit. Rev. Oncog. 4:1993;25-52.
16. Parkin D.M., Muir C.S., Whelan S.L., Gao Y.T., Fenlay J., Powell J. Cancer Incidence in Five Continents. IARC Scientific Publication 120. 6:1992;IARC.
17. Battisa S., de Nigris F., Fedele M., Chiappetta G., Scala S., Vallone D., Pierantoni G.M., Mega T., santoro M., Viglietto G., Verde P., Fusco A., Megar T. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene. 17:1998;377-385.
18. Sui L., Dong Y., Ohno M., Watanabe Y., Sugimoto K., Tai Y., Tokuda M. Jab1 expression in associated with inverse expression of p27/kip1 and poor prognosis in epithelial ovarian tumors. Clin. Cancer Res. 7:2001;4130-4135.
19. Korbonits M., Chahal H.S., Kaltsas G., Jordan S., Urmanova Y., Khalimova Z., Harris P.E., Farrell W.E., Claret F.X., Grossman A.B. Expression of phosphorylated p27 protein and jun activation domain-binding protein 1 in human pituitary tumors. J. Clin. Endocrinol. Metab. 87:2002;2635-2643.
20. Wan M., Cao X., Wu Y., Bai S., Wu L., Shi X., Wang N., Cao X. Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO rep. 3:2002;171-176.
21. West J., Monoz-Antonia T., Johnson J.G., Klotch D., Muro-Cacho C.A. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors. Laryngoscope. 110:2000;1323-1327.
22. Hedlin N.E., Bergstrom D., Hermansson, Bergenstrahle A., Nakao A., Westermark B., ten Dijke P. Lack of responsiveness to TGF-beta 1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptor and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells. Mol. Cell Endocrinol. 153:1999;79-90.